Optimal control of dosage decisions in controlled ovarian hyperstimulation
暂无分享,去创建一个
Warren B. Powell | Lei Zhao | Miao He | Warrren B Powell | M. He | Lei Zhao
[1] Andrew J. Schaefer,et al. The Optimal Timing of Living-Donor Liver Transplantation , 2004, Manag. Sci..
[2] Serge Rozenberg,et al. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). , 2003, Human reproduction update.
[3] A. Loft,et al. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation. , 1999, Human reproduction.
[4] Richard S Legro,et al. Polycystic ovary syndrome , 2007, The Lancet.
[5] Alejandro C. Arroliga,et al. Ovarian hyperstimulation syndrome , 2005, Critical care medicine.
[6] Andrew J. Schaefer,et al. Determining the Acceptance of Cadaveric Livers Using an Implicit Model of the Waiting List , 2007, Oper. Res..
[7] David C. Schmittlein,et al. A Live Baby or Your Money Back: The Marketing of In Vitro Fertilization Procedures , 2003, Manag. Sci..
[8] S. Stone,et al. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. , 1991, Human reproduction.
[9] A. Knutsson,et al. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. , 2001, Human reproduction.
[10] Barry L. Nelson,et al. Autoregressive to anything: Time-series input processes for simulation , 1996, Oper. Res. Lett..
[11] L. Rombauts,et al. Is there a recommended maximum starting dose of FSH in IVF? , 2007, Journal of Assisted Reproduction and Genetics.
[12] W P Collins,et al. Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome. , 1995, Human reproduction.
[13] Young Min Choi,et al. Clinical Efficacy of Body Mass Index as Predictor of In Vitro Fertilization and Embryo Transfer Outcomes , 2006, Journal of Korean medical science.
[14] Andrew J. Schaefer,et al. Choosing Among Living-Donor and Cadaveric Livers , 2007, Manag. Sci..
[15] He-Feng Huang,et al. Poor Responder-high Responder: The Importance Of Follicle Stimulating Hormone Receptor In Ovarian Stimulation Protocols , 2005 .
[16] M. Sauer,et al. Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles. , 2002, Human reproduction.
[17] J R Marshall,et al. Ovulation induction. , 1970, Obstetrics and gynecology.
[18] J. Banks,et al. Discrete-Event System Simulation , 1995 .
[19] Marinus J Eijkemans,et al. Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome. , 2006, Fertility and sterility.
[20] Tom Searle,et al. The value of routine estradiol monitoring in assisted conception cycles , 2002, Acta obstetricia et gynecologica Scandinavica.
[21] L P Hunt,et al. Distinction between early and late ovarian hyperstimulation syndrome. , 2000, Fertility and sterility.
[22] A. C. Wentz,et al. Evaluation of the exponential rise of serum estradiol concentrations in human menopausal gonadotropin-induced cycles. , 1983, Fertility and sterility.
[23] A. Schmidt,et al. High peak serum estradiols during IVF-ET impair pregnancy and implantation rates , 2004 .
[24] Serge Rozenberg,et al. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. , 2002, Human reproduction update.
[25] Denny Sakkas,et al. Impact of duration and dose of gonadotrophins on IVF outcomes. , 2006, Reproductive biomedicine online.
[26] J G Grudzinskas,et al. Prevention and treatment of ovarian hyperstimulation syndrome. , 2003, Best practice & research. Clinical obstetrics & gynaecology.
[27] Gautam N Allahbadia,et al. Manual of Ovulation Induction , 2005 .
[28] Mika Gissler,et al. Complications of IVF and ovulation induction. , 2005, Human reproduction.
[29] N. Macklon,et al. What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment. , 2004, Human reproduction.
[30] Barry L. Nelson,et al. Modeling and generating multivariate time-series input processes using a vector autoregressive technique , 2003, TOMC.
[31] J. Balasch,et al. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. , 2001, Human reproduction.
[32] Barry L. Nelson,et al. Numerical Methods for Fitting and Simulating Autoregressive-to-Anything Processes , 1998, INFORMS J. Comput..
[33] Benjamin Van Roy,et al. Approximate Dynamic Programming via Linear Programming , 2001, NIPS.
[34] Y. Soong,et al. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. , 1998, Fertility and sterility.
[35] M. Aboulghar,et al. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. , 2003, Human reproduction update.
[36] J. Grossman,et al. Building a Better Delivery System: A New Engineering/Health Care Partnership , 2005 .
[37] Warren B. Powell,et al. Approximate Dynamic Programming - Solving the Curses of Dimensionality , 2007 .
[38] E. Puscheck,et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. , 2003, Fertility and sterility.
[39] R. Barbieri,et al. Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues. , 1999, Endocrine reviews.
[40] François Goffinet,et al. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. , 2002, Human reproduction.
[41] Robert L. Collins,et al. Office-Based Infertility Practice , 2002, Springer New York.
[42] James P. Toner,et al. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization , 1989, Journal of in Vitro Fertilization and Embryo Transfer.
[43] E A Wilson,et al. Rates of exponential increase of serum estradiol concentrations in normal and human menopausal gonadotropin-induced cycles. , 1982, Fertility and sterility.
[44] W. Crowley,et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. , 1999, Human reproduction.
[45] Barry L. Nelson,et al. Fitting Time-Series Input Processes for Simulation , 2005, Oper. Res..